Ketcher 11132014122D 1 1.00000 0.00000 0 28 29 0 1 0 999 V2000 7.8085 -18.2386 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.6006 -19.2167 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 7.0654 -17.5694 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.6495 -19.5256 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.1143 -17.8784 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 5.9064 -18.8565 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 6.4415 -20.5038 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 5.3712 -17.2092 0.0000 Cl 0 0 0 0 0 0 0 0 0 0 0 0 8.7595 -17.9295 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.9674 -16.9514 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 8.2983 -16.2083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 9.8810 -16.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 8.7983 -15.3422 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 9.7764 -15.5500 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 10.7470 -17.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.6130 -16.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.4791 -17.0447 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0 13.3451 -16.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 -17.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 11.6130 -15.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 12.4791 -15.0447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 10.7470 -15.0447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 13.3451 -15.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 -15.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 15.0772 -15.5447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 -14.0447 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0 14.2111 -18.0446 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 15.0772 -16.5447 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0 1 2 1 0 0 0 1 3 2 0 0 0 2 4 2 0 0 0 3 5 1 0 0 0 4 6 1 0 0 0 5 6 2 0 0 0 4 7 1 0 0 0 5 8 1 0 0 0 1 9 1 0 0 0 9 10 1 0 0 0 10 11 1 0 0 0 10 12 1 0 0 0 11 13 2 0 0 0 12 14 2 0 0 0 13 14 1 0 0 0 12 15 1 0 0 0 16 15 1 1 0 0 16 17 1 0 0 0 17 18 1 0 0 0 18 19 1 0 0 0 16 20 1 0 0 0 20 21 2 0 0 0 20 22 1 0 0 0 18 23 1 1 0 0 23 24 1 0 0 0 24 25 1 0 0 0 24 26 1 0 0 0 19 27 2 0 0 0 19 28 1 0 0 0 M END > CHEBI:166834 > MLN-4760 > A L-histidine derivative that is L-histidine in which a hydrogen of the primary amino group is substituted by a (1S)-1-carboxy-3-methylbutyl group and the ring NH group is substituted by a 3,5-dichlorobenzyl group. It is a potent and selective human angiotensin-converting enzyme 2 (ACE2) inhibitor (IC50 = 0.44 nM) which was in clinical development for the treatment of ulcerative colitis. > 3 > CHEBI:47755 > ORE1001; ORE-1001 free acid; ORE-1001; N-[(1S)-1-carboxy-3-methylbutyl]-3-[(3,5-dichlorophenyl)methyl]-L-histidine; MLN4760; GL1001; GL-1001; 2(S)-(1(S)-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)-ethylamino)-4-methylpentanoic acid; (S,S)-2-(1-carboxy-2-(3-(3,5-dichlorobenzyl)-3H-imidazol-4-yl)-ethylamino)-4-methylpentanoic acid > N-[(1S)-1-carboxy-3-methylbutyl]-3-(3,5-dichlorobenzyl)-L-histidine > C19H23Cl2N3O4 > 428.310 > 427.10656 > 0 > CC(C)C[C@H](N[C@@H](CC1=CN=CN1CC1=CC(Cl)=CC(Cl)=C1)C(O)=O)C(O)=O > InChI=1S/C19H23Cl2N3O4/c1-11(2)3-16(18(25)26)23-17(19(27)28)7-15-8-22-10-24(15)9-12-4-13(20)6-14(21)5-12/h4-6,8,10-11,16-17,23H,3,7,9H2,1-2H3,(H,25,26)(H,27,28)/t16-,17-/m0/s1 > NTCCRGGIJNDEAB-IRXDYDNUSA-N > 305335-31-3 > 305335-31-3 > DB12271 > LSM-45511 > XX5 > 14754895; 18243695; 18324760; 18356558; 19517214; 26851370; 27302421; 30806090; 31356776; 31393582; 32368013; 32866470; 33122196 $$$$